The 16oz Pharma Oblong is suitable for prescription and over-the-counter (OTC) liquid pharmaceutical products. There bottle is supplied with a variety of child-resistant and standard continuous threaded closures. The bottle surface has an indented panel that is easy to personalise.
Both bottles and closures are supported with data indicating US FDA compliance.
O Berk pharma bottle is ready to ship
HDPE Pharma Oblong in amber now available from stock
You may also like
Analysis
Compact, cost-effective flow sensor with differential pressure technology developed for demanding laboratory systems
Read moreBürkert, a pioneer in flow control, has announced the release of a new flow sensor using differential pressure technology that offers enhanced performance from continuous measurement alongside increased process safety in a space-saving, cost-effective design
Trending Articles
You may also like
Analysis
Compact, cost-effective flow sensor with differential pressure technology developed for demanding laboratory systems
Bürkert, a pioneer in flow control, has announced the release of a new flow sensor using differential pressure technology that offers enhanced performance from continuous measurement alongside increased process safety in a space-saving, cost-effective design
Design & Build
Celebrating 30 years of Maggie's and the Lives it's changed
A cancer diagnosis touches every part of life. For thirty years, Maggie’s has offered practical and emotional support and a place to belong, alongside medical treatment - for the parts of a cancer diagnosis that no prescription can reach
Manufacturing
Titan Enterprises develops PFAS-free material options for turbine flowmeters
Titan Enterprises is evaluating high-performance, PFAS-free polymers for its turbine flowmeter range, aiming to maintain accuracy, durability and reliability while preparing for evolving international regulations
Manufacturing
What makes a GMP quality system effective in day-to-day pharmaceutical manufacturing?
Your quality system may have a procedure for almost everything: reporting a deviation, reviewing a batch record, changing equipment settings and training the people who operate it. But having a procedure and getting a useful answer from it are two different things
Regulatory
Pheno Therapeutics secures two patents for neurological drug pipeline
The Edinburgh-based biotech has strengthened its intellectual property portfolio for two selective GPR17 antagonists, including its lead multiple sclerosis candidate, PTD802, which has US and UK regulatory clearance to enter clinical trials
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.